Edinburgh Research Explorer

Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease

Research output: Contribution to journalArticle

Standard

Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease. / Farrah, Tariq E.; Anand, Atul; Gallacher, Peter J.; Kimmitt, Robert; Carter, Edwin; Dear, James W.; Mills, Nicholas L.; Webb, David J.; Dhaun, Neeraj.

In: Hypertension, Vol. 74, No. 2, 08.2019, p. 323-330.

Research output: Contribution to journalArticle

Harvard

Farrah, TE, Anand, A, Gallacher, PJ, Kimmitt, R, Carter, E, Dear, JW, Mills, NL, Webb, DJ & Dhaun, N 2019, 'Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease', Hypertension, vol. 74, no. 2, pp. 323-330. https://doi.org/10.1161/HYPERTENSIONAHA.119.12919

APA

Farrah, T. E., Anand, A., Gallacher, P. J., Kimmitt, R., Carter, E., Dear, J. W., ... Dhaun, N. (2019). Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease. Hypertension, 74(2), 323-330. https://doi.org/10.1161/HYPERTENSIONAHA.119.12919

Vancouver

Farrah TE, Anand A, Gallacher PJ, Kimmitt R, Carter E, Dear JW et al. Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease. Hypertension. 2019 Aug;74(2):323-330. https://doi.org/10.1161/HYPERTENSIONAHA.119.12919

Author

Farrah, Tariq E. ; Anand, Atul ; Gallacher, Peter J. ; Kimmitt, Robert ; Carter, Edwin ; Dear, James W. ; Mills, Nicholas L. ; Webb, David J. ; Dhaun, Neeraj. / Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease. In: Hypertension. 2019 ; Vol. 74, No. 2. pp. 323-330.